Amedisys Q2 Revenue Beats Target, Earnings Miss

Amedisys AMED reports its Q2 EPS at $1.13, falling short of the consensus of $1.15. AMED’s Q2 revenue came in at $422.3 million versus the estimates of $421.26 million. AMED’s shares lost 2.65% to $26.08 in after-hours trading. Read more from Benzinga's Company news. See Some of the Top Moving Indexes Here.